Literature DB >> 30310935

[Sacral neuromodulation for refractory overactive bladder].

Arndt van Ophoven1.   

Abstract

Sacral neuromodulation (SNM) is a minimally invasive, established treatment modality for overactive bladder (OAB) as well as for other pelvic functional disorders, such as non-obstructive urinary retention and fecal incontinence. A pacemaker implanted in the upper buttocks delivers mild electrical pulses to the sacral nerves thereby modulating pathological afferent signals from pelvic end organs. The current article conveys the current knowledge on the indications, contraindications, mechanism of action, implantation technique, efficacy and complications of SNM for the treatment refractory OAB.

Entities:  

Keywords:  Efficacy; Implanted stimulation electrodes; Mechanism of action; Overactive bladder; Sacral neuromodulation

Mesh:

Year:  2018        PMID: 30310935     DOI: 10.1007/s00120-018-0777-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  51 in total

1.  Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors:  R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

Review 2.  Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011.

Authors:  Anna P Malykhina; Jean-Jacques Wyndaele; Karl-Erik Andersson; Stefan De Wachter; Roger R Dmochowski
Journal:  Neurourol Urodyn       Date:  2012-02-29       Impact factor: 2.696

Review 3.  Neuromodulation 10 years on: how widely should we use this technique in bladder dysfunction?

Authors:  John F Bolton; Simon C W Harrison
Journal:  Curr Opin Urol       Date:  2009-07       Impact factor: 2.309

4.  Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study.

Authors:  A C van Voskuilen; D J A J Oerlemans; E H J Weil; R A de Bie; Ph E V A van Kerrebroeck
Journal:  Eur Urol       Date:  2006-01-04       Impact factor: 20.096

5.  International Continence Society best practice statement for use of sacral neuromodulation.

Authors:  Howard B Goldman; Jessica C Lloyd; Karen L Noblett; Marcus P Carey; Juan Carlos Castaño Botero; Jerzy B Gajewski; Paul A Lehur; Magdy M Hassouna; Klaus E Matzel; Ian M Paquette; Stefan de Wachter; Michael J Ehlert; Emmanuel Chartier-Kastler; Steven W Siegel
Journal:  Neurourol Urodyn       Date:  2018-04-11       Impact factor: 2.696

6.  Bladder pacemaker: scientific basis and clinical future.

Authors:  E A Tanagho; R A Schmidt
Journal:  Urology       Date:  1982-12       Impact factor: 2.649

7.  Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?

Authors:  Thomas M Kessler; Helmut Madersbacher; Gustav Kiss
Journal:  Eur Urol       Date:  2005-01-04       Impact factor: 20.096

8.  A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation.

Authors:  K Everaert; W Kerckhaert; H Caluwaerts; M Audenaert; H Vereecke; G De Cuypere; A Boelaert; U Van den Hombergh; W Oosterlinck
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

Review 9.  Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety.

Authors:  Michele Spinelli; Karl-Dietrich Sievert
Journal:  Eur Urol       Date:  2008-02-08       Impact factor: 20.096

10.  Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity.

Authors:  Christina L Fontaine; Ian Rudd; Mahreen Pakzad; Rizwan Hamid; Jeremy L Ockrim; Tamsin J Greenwell
Journal:  Urol Ann       Date:  2017 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.